Immune checkpoint blockade in renal cell carcinoma

Immune checkpoint blockade in renal cell carcinoma

Show other versions (2)
Saved in:
Bibliographic Details
Other Authors: McDermott, David (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2016.
Series:Henry Stewart talks. Biomedical & life sciences collection. Immunotherapy of cancer.
Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease.
Subjects:
Antineoplastic agents.
Cancer > Immunological aspects.
Immunotherapy.
Kidneys > Cancer > Chemotherapy.
Kidneys > Cancer > Immunological aspects.
Renal cell carcinoma.
Antibodies, Monoclonal > therapeutic use.
Antineoplastic Agents > therapeutic use.
Carcinoma, Renal Cell > drug therapy.
Carcinoma, Renal Cell > immunology.
Cell Cycle Checkpoints.
Clinical Trials as Topic.
Combined Modality Therapy.
CTLA-4 Antigen > immunology.
Immunotherapy > methods.
Kidney Neoplasms > drug therapy.
Kidney Neoplasms > immunology.
Patient Selection.
Programmed Cell Death 1 Receptor > antagonists & inhibitors.
T-Lymphocytes > immunology.
Online Access:https://hstalks.com/bs/3242/
Series (Immunotherapy of cancer)
Series (Kidney in health and disease)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Contents: Recent data that has led to the approval of PD-1 blockade in RCC
  • Approaches to patient selection
  • Novel combination therapies that are entering pivotal trials.

Similar Items